Billy Dunn

16.8k total citations · 2 hit papers
22 papers, 1.4k citations indexed

About

Billy Dunn is a scholar working on Epidemiology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Billy Dunn has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 4 papers in Pathology and Forensic Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Billy Dunn's work include Cerebrovascular and Carotid Artery Diseases (3 papers), Alcohol Consumption and Health Effects (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Billy Dunn is often cited by papers focused on Cerebrovascular and Carotid Artery Diseases (3 papers), Alcohol Consumption and Health Effects (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Billy Dunn collaborates with scholars based in United States, Netherlands and United Kingdom. Billy Dunn's co-authors include Patrizia Cavazzoni, Peter Stein, Charlotte E. Teunissen, Reisa A. Sperling, Philip Scheltens, Oskar Hansson, William J. Jagust, José Luís Molinuevo, Marı́a C. Carrillo and Clifford R. Jack and has published in prestigious journals such as Hepatology, Neurology and Nature Reviews Drug Discovery.

In The Last Decade

Billy Dunn

20 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup

2024 776 citations Clifford R. Jack, J. Scott Andrews et al. Alzheimer s & Dementia profile →
Approval of Aducanumab for Alzheimer Disease—The FDA’s Perspective

2021 174 citations Billy Dunn, Peter Stein et al. JAMA Internal Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Billy Dunn United States	11	493	454	265	209	208	22	1.4k
R. C. Green United States	9	545 1.1×	524 1.2×	237 0.9×	210 1.0×	269 1.3×	11	1.3k
Cécile Tissot Canada	23	765 1.6×	582 1.3×	300 1.1×	222 1.1×	186 0.9×	89	1.6k
Ya‐Hui Ma China	23	629 1.3×	580 1.3×	215 0.8×	318 1.5×	398 1.9×	94	2.2k
Astrid Kok Netherlands	17	748 1.5×	710 1.6×	173 0.7×	321 1.5×	245 1.2×	22	1.7k
Gerard Piñol‐Ripoll Spain	24	467 0.9×	320 0.7×	193 0.7×	373 1.8×	177 0.9×	88	1.7k
Michael Jonsson Sweden	18	539 1.1×	495 1.1×	239 0.9×	285 1.4×	465 2.2×	31	1.6k
Tim West United States	25	1.0k 2.0×	396 0.9×	209 0.8×	501 2.4×	230 1.1×	63	2.4k
Alfredo Postiglione Italy	24	275 0.6×	272 0.6×	189 0.7×	177 0.8×	102 0.5×	56	1.5k
Gregory M. Preboske United States	15	524 1.1×	446 1.0×	110 0.4×	151 0.7×	198 1.0×	21	1.1k
Wei Qin China	22	540 1.1×	284 0.6×	211 0.8×	540 2.6×	404 1.9×	89	1.8k

Countries citing papers authored by Billy Dunn

Since Specialization

Citations

This map shows the geographic impact of Billy Dunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Billy Dunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Billy Dunn more than expected).

Fields of papers citing papers by Billy Dunn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Billy Dunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Billy Dunn. The network helps show where Billy Dunn may publish in the future.

Co-authorship network of co-authors of Billy Dunn

This figure shows the co-authorship network connecting the top 25 collaborators of Billy Dunn. A scholar is included among the top collaborators of Billy Dunn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Billy Dunn. Billy Dunn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cummings, Jeffrey L., Charlotte E. Teunissen, Brian Fiske, et al.. (2025). Biomarker-guided decision making in clinical drug development for neurodegenerative disorders. Nature Reviews Drug Discovery. 24(8). 589–609. 9 indexed citations

Simuni, Tanya, Caroline Gochanour, Michael C. Brumm, et al.. (2025). Neuronal α‐Synuclein Disease Stage Progression over 5 Years. Movement Disorders. 40(7). 1318–1330.

Moatti, Adele, Billy Dunn, Mani Ratnam, et al.. (2024). Surgical procedure of intratympanic injection and inner ear pharmacokinetics simulation in domestic pigs. Frontiers in Pharmacology. 15. 1348172–1348172. 6 indexed citations

Jack, Clifford R., J. Scott Andrews, Thomas G. Beach, et al.. (2024). Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup. Alzheimer s & Dementia. 20(8). 5143–5169. 776 indexed citations breakdown →

Bhattaram, Atul, Kevin Krudys, Ramana Uppoor, et al.. (2022). Extrapolation of Efficacy from Adults to Pediatric Patients of Drugs for Treatment of Partial Onset Seizures: A Regulatory Perspective. Clinical Pharmacology & Therapeutics. 112(4). 853–863. 5 indexed citations

Dunn, Billy, Peter Stein, & Patrizia Cavazzoni. (2021). Approval of Aducanumab for Alzheimer Disease—The FDA’s Perspective. JAMA Internal Medicine. 181(10). 1276–1276. 174 indexed citations breakdown →

Im, Gene Y., Jessica L. Mellinger, Adam C. Winters, et al.. (2020). Provider Attitudes and Practices for Alcohol Screening, Treatment, and Education in Patients With Liver Disease: A Survey From the American Association for the Study of Liver Diseases Alcohol-Associated Liver Disease Special Interest Group. Clinical Gastroenterology and Hepatology. 19(11). 2407–2416.e8. 76 indexed citations

Xu, Li, Ilan Irony, Wilson W. Bryan, & Billy Dunn. (2017). Development of gene therapies—lessons from nusinersen. Gene Therapy. 24(9). 527–528. 8 indexed citations

Weninger, Stacie, María C. Carrillo, Billy Dunn, et al.. (2016). Collaboration for Alzheimer's Prevention: Principles to guide data and sample sharing in preclinical Alzheimer's disease trials. Alzheimer s & Dementia. 12(5). 631–632. 16 indexed citations

10.

Dunn, Billy, et al.. (2016). “Bath Salts” the New York City Medical Examiner Experience: A 3‐Year Retrospective Review. Journal of Forensic Sciences. 62(3). 695–699. 13 indexed citations

11.

Lin, Peter T. & Billy Dunn. (2013). Suicidal Carbon Monoxide Poisoning by Combining Formic Acid and Sulfuric Acid Within a Confined Space. Journal of Forensic Sciences. 59(1). 271–273. 10 indexed citations

12.

Saver, Jeffrey L., Gregory W. Albers, Billy Dunn, Karen C. Johnston, & Marc Fisher. (2009). Stroke Therapy Academic Industry Roundtable (STAIR) Recommendations for Extended Window Acute Stroke Therapy Trials. Stroke. 40(7). 2594–2600. 112 indexed citations

13.

Dunn, Billy & Jeffrey B. Schwimmer. (2008). Reply:. Hepatology. 48(3). 1023–1024. 2 indexed citations

14.

Dunn, Billy, et al.. (2007). A Method for the Estimation of Drug Concentrations in Dried Bloodstains.

15.

Chalela, Julio A., et al.. (2005). Induced hypertension improves cerebral blood flow in acute ischemic stroke. Neurology. 64(11). 1979–1979. 26 indexed citations

16.

Chalela, Julio A., Dong‐Wha Kang, Marie Luby, et al.. (2003). Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome: Insights into the pathophysiology of acute stroke in the thrombolysis era. Annals of Neurology. 55(1). 105–112. 92 indexed citations

17.

Dunn, Billy, et al.. (1994). A Report of a Suicide Involving Digoxin and Doxepin. Journal of Analytical Toxicology. 18(2). 122–123. 9 indexed citations

18.

Dunn, Billy & Theodore J. Siek. (1990). A Rapid, Sensitive, and Specific Screening Technique for the Determination of Cyanide. Journal of Analytical Toxicology. 14(4). 256–256. 10 indexed citations

19.

Dunn, Billy, et al.. (1984). Hydrofluoric acid poisoning. American Journal of Forensic Medicine & Pathology. 5(3). 245–248. 24 indexed citations

20.

Kilburn, J O, et al.. (1972). Reagent-Impregnated Paper Strip for Detection of Metabolic Products of Isoniazid in Urine ¹. American Review of Respiratory Disease. 106(6). 923–924. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact